Cowealth Medical China Co.,Ltd. (SHA:603122)

China flag China · Delayed Price · Currency is CNY
16.68
-0.40 (-2.34%)
At close: Mar 9, 2026
123.59%
Market Cap 6.64B
Revenue (ttm) 777.03M
Net Income (ttm) -11.37M
Shares Out 398.05M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend 0.13 (0.76%)
Ex-Dividend Date Jul 14, 2025
Volume 12,572,100
Average Volume 22,541,521
Open 16.90
Previous Close 17.08
Day's Range 16.41 - 17.06
52-Week Range 5.56 - 31.22
Beta -0.00
RSI 40.93
Earnings Date Mar 14, 2026

About Cowealth Medical China

Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers management services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company was founded in 1997 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 1997
Employees 203
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603122
Full Company Profile

Financial Performance

In 2024, Cowealth Medical China's revenue was 939.14 million, a decrease of -14.05% compared to the previous year's 1.09 billion. Earnings were 27.57 million, a decrease of -41.58%.

Financial Statements

News

There is no news available yet.